Linked Life Data

11114313

Source:http://linkedlifedata.com/resource/pubmed/id/11114313

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
24
pubmed:dateCreated
2000-12-1
pubmed:abstractText
Fludarabine is an effective treatment for chronic lymphocytic leukemia that does not respond to initial treatment with chlorambucil. We compared the efficacy of fludarabine with that of chlorambucil in the primary treatment of chronic lymphocytic leukemia.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0028-4793
pubmed:author
pubmed:issnType
Print
pubmed:day
14
pubmed:volume
343
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1750-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11114313-Administration, Oral, pubmed-meshheading:11114313-Adult, pubmed-meshheading:11114313-Aged, pubmed-meshheading:11114313-Antineoplastic Agents, pubmed-meshheading:11114313-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11114313-Chlorambucil, pubmed-meshheading:11114313-Cross-Over Studies, pubmed-meshheading:11114313-Disease-Free Survival, pubmed-meshheading:11114313-Female, pubmed-meshheading:11114313-Humans, pubmed-meshheading:11114313-Infusions, Intravenous, pubmed-meshheading:11114313-Leukemia, Lymphocytic, Chronic, B-Cell, pubmed-meshheading:11114313-Male, pubmed-meshheading:11114313-Middle Aged, pubmed-meshheading:11114313-Neoplasm Staging, pubmed-meshheading:11114313-Prospective Studies, pubmed-meshheading:11114313-Remission Induction, pubmed-meshheading:11114313-Survival Analysis, pubmed-meshheading:11114313-Vidarabine
pubmed:year
2000
pubmed:articleTitle
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
pubmed:affiliation
Cancer and Leukemia Group B, Chicago, USA. rai@lij.edu
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study